Dear WMSHP Community,
Please join us for a virtual CE event from 6:00 pm to 8:15 pm on Wednesday, February 19, 2025.
Link to attend will be shared with registered attendees after registration closes
Registration closes on February 18, 2025 at 5:00 PM
If already registered and not able to attend, please email WMSHP Secretary at webwmshp@gmail.com before registration closure.
Brief Schedule at a glance:
6:00 PM - 6:05 PM - WMSHP Leadership to give Introductory Remarks and Moderate Zoom Seminar
Followed by CE session (and respective opportunities for interactive questions with speaker)
6: 05 – 7:05 PM: “Tranexamic Acid Use in Intracerebral Hemorrhage” by Amanda Koluda, PharmD (ACPE UAN: 0025-9999-25-036-L01-P)
7: 05 PM - 8:05 PM: “Managing Lyme Carditis” by Victoria Ly, PharmD, BCCP (ACPE UAN: 0025-9999-25-026-L01-P)
8:05 PM – 8:15 PM: Closing Remarks and Acknowledgements by WMSHP Leadership
Kindly mute to ensure minimal distractions to the speakers
Link for CE credit will be shared at the end of the program
(Zoom Chat box)
From all of us in WMSHP Leadership, we look forward to seeing you on February 19th!
Click link below for more information and a detailed schedule:
Wednesday February 19 2025 WMSHP CE Program.pdf
Transexamic Acid Use in Intracerebral Hemorrhage: Tranexamic acid is being studied for many intracranial hemorrhage related indications, including intracerebral hemorrhage. The risk-benefit of its use in this indication is not fully established. The TICH-2 trial recently released their one-year outcomes, bringing some new information to the topic. This presentation will address the literature so far with the new one-year study as well as touch upon future direction with the TICH-3.
Managing Lyme Carditis: Lyme carditis definition, pathophysiology, clinical presentation as well as both pharmacological and non-pharmacological treatments will be discussed. A patient case study will also be discussed to review and apply knowledge content.
.png)
